MSI-H/dMMR癌症的流行病学,致病性,生物学和不断变化的管理
Margherita Ambrosini1,2, Paolo Manca1,3, Vincenzo Nasca1
1Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Nature reviews. Clinical oncology
|April 3, 2025
概括
缺少DNA不匹配修复 (dMMR) 导致微卫星不稳定性高 (MSI-H) 瘤. 这些MSI-H/dMMR癌症对免疫检查点抑制剂具有高度敏感性,无论瘤类型如何.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 缺少DNA不匹配修复 (dMMR) 是致癌的一个关键驱动因素,导致各种癌症的微卫星不稳定性高 (MSI-H) 现型.
- MSI-H/dMMR表型在子宫内膜和结直肠癌中最常见,影响瘤生物学,预后和治疗反应.
- 林奇综合征是一种遗传性疾病,是MSI-H/dMMR癌症的一个子集,这引发了关于遗传与零星瘤行为的问题.
研究的目的:
- 为了提供MSI-H/dMMR瘤作为组织学不可知现象的全面概述.
- 探索MSI-H/dMMR癌症的流行病学,生物学,发病,诊断和治疗.
- 要突出与MSI-H/dMMR瘤内的特定遗传变化和组织学相关的独特特征.
主要方法:
- 对DNA不匹配修复缺陷和微卫星不稳定性高的癌症现有文献的审查.
- 对流行病学数据,生物机制和临床结果的分析.
- 综合有关治疗反应的信息,特别是对免疫检查点抑制剂的信息.
主要成果:
- MSI-H/dMMR表型与独特的瘤生物学,预后和治疗敏感性有关.
- 转移性MSI-H/dMMR癌症由于高突变和免疫性,对免疫检查点抑制剂 (ICI) 具有很高的敏感性.
- 早期疾病也受益于ICI策略,组织型特异性特征可能会影响预后和ICI反应.
结论:
- MSI-H/dMMR瘤代表了一个重要的分子亚型,在癌症类型中具有广泛的影响.
- 这些瘤的免疫性质呈现出一种可被ICI利用的治疗脆弱性,无论是在转移还是早期阶段.
- 了解组织型特异性特征对于优化治疗策略和预测MSI-H/dMMR癌症的结果至关重要.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
15:24Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
3.0K
相关概念视频
01:20Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K